OR WAIT null SECS
April 01, 2020
Understanding European GMPs and new rules from China for excipients are crucial for formulating solid-dosage drugs.
March 19, 2020
Synairgen, a respiratory drug discovery and development company, has announced that it has received expedited approvals to conduct a trial of its inhaled formulation of interferon-beta-1a, SNG001, in COVID-19 patients.
March 02, 2020
Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.
Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?
Formulating fixed-dose combination drugs proves more complex than simply adding one ingredient to another.
February 21, 2020
Researchers at the Technical University of Munich (TUM) have discovered a way of continuously and precisely dosing active agents using an oil-hydrogel mixture.
February 13, 2020
The companies have entered into a global licensing and collaboration agreement to commercialize ReForm excipients used in biotherapeutic formulations.
February 02, 2020
Lipid-based solutions offer a natural approach to improving the solubility of cannabinoid-derived products.
This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.
January 10, 2020
Generic pharmaceutical company, Hikma Pharmaceuticals, and biopharmaceutical company, Arecor, have entered into an exclusive agreement for the development and commercialization of a ready-to-use injectable medicine.